Epilepsy Clinical Trials in Philadelphia

Showing 21-40 of 71 trials

A Taste and Acceptance Study of FruitiVits in Children Aged 4-8 Years Following a Ketogenic Diet.

NCT02229318

Subjects will be asked to substitute their usual vitamin and mineral supplement/s with FruitiVits for seven consecutive days.

Seizure Disorders

Vitaflo International, Ltd11 participantsStarted Sep 2014

Philadelphia, Pennsylvania, United States

COMPLETED< 1 mile

Human Epilepsy Project 2: Resistant Focal Seizures Study

NCT03531008

The HEP2 study is designed to better understand the challenges of living with focal seizures that do not respond to medication, by following 205 people with medication-resistant focal epilepsy over two years to measure changes in health status, healthcare costs, quality of life, and biomarkers of epilepsy severity and treatment response.

EpilepsyBrain DiseasesCentral Nervous System Diseases+2 more

Epilepsy Foundation of America157 participantsStarted May 2018

San Francisco, California, United States • New Haven, Connecticut, United States • Miami, Florida, United States +7 more locations

UNKNOWNPHASE2< 1 mile

Safety, Tolerability, and Exploratory Efficacy of Adjunctive EQU-001 for Seizures in Adults With Epilepsy

NCT05063877

This is a double-blind, placebo controlled, randomized study of dose-ranging safety, tolerability, exploratory efficacy of adjunctive EQU-001 for seizures using the continuous reassessment method in patients diagnosed with epilepsy.

Epilepsy

Equilibre Biopharmaceuticals B.V.43 participantsStarted Aug 2021

Boise, Idaho, United States • Bethesda, Maryland, United States • Hackensack, New Jersey, United States +7 more locations

A Taste and Acceptance Study of FruitiVits in Children Aged 4-8 Years Following a Ketogenic Diet.

Human Epilepsy Project 2: Resistant Focal Seizures Study

Safety, Tolerability, and Exploratory Efficacy of Adjunctive EQU-001 for Seizures in Adults With Epilepsy

Epilepsy Trials in Other Cities

A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures

A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601

Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Epilepsy

Staccato Alprazolam and Photoparoxysmal Response

Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures

Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern

A Study to Evaluate the Pharmacodynamic Activity of E2082 in Adult Participants With Photosensitive Epilepsy

Intravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status Epilepticus

Pharmacokinetics of Anti-epileptic Drugs in Obese Children

Study of Adjunctive Ganaxolone Treatment in Female Children With Protocadherin 19 (PCDH19)-Related Epilepsy (Violet Study)

Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study

Neuroimaging Biomarker for Seizures

Gene-STEPS: Shortening Time of Evaluation in Paediatric Epilepsy Services

Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery

A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects <4 Years of Age With Partial Onset Seizures.

A Study to Look at the Efficacy and Safety of Keppra® Extended Release Formulation - XR

Other Conditions in Philadelphia